NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required)
ID: 344740Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/344740

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-057.html
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for the NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required), aimed at supporting multi-site investigator-initiated clinical trials that align with the National Institute on Aging's (NIA) mission of health and aging research. The funding opportunity seeks well-designed trials that address significant health issues among older adults, emphasizing the importance of timely publication of results and compliance with regulatory standards. This grant is open to a diverse range of eligible applicants, including higher education institutions, nonprofits, and governmental entities, with a project period of up to five years and multiple submission deadlines from March 2023 to February 2025. Interested applicants can find more information and application instructions at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-057-Full-Announcement.html
    PAR-23-057.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), invites applications for the NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required). This funding opportunity aims to support multi-site investigator-initiated clinical trials relevant to the NIA's mission of health and aging research. Eligible applicants include various higher education institutions, nonprofits, for-profit organizations, and governmental entities. Key dates for submission include multiple deadlines from March 2023 to February 2025, with a project period of up to five years. The funding opportunity emphasizes trials that are well-designed, address significant health issues among older adults, and provide timely publication of results. Applicants must follow specific application instructions and ensure compliance with various regulatory bodies. The review criteria include project significance, investigator qualifications, innovation, approach, and environment. Successful applications will reflect strong scientific and technical merit, aligning with NIA's priorities. This opportunity showcases the NIH's commitment to advancing clinical research that tackles complex health challenges faced by an aging population.
    Similar Opportunities
    NIA Renewal and Competing Revision Cooperative Agreements in Aging Research (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Funding Opportunity Announcement (FOA) for renewal and competing revision applications focused on aging research, designated as U01 Clinical Trial Optional. This initiative aims to support research projects that address critical issues related to aging, including Alzheimer's disease and related dementias, thereby facilitating advancements in public health. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, for-profit entities, governmental agencies, and foreign institutions, with no cost-sharing or matching requirements. Interested parties should note that applications are due by October 1, 2024, and can find further details and application guidelines at the NIH website or by contacting the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Healthcare for Older Adults from Populations that Experience Health Disparities" under the R01 Clinical Trial Optional grant program. This initiative aims to enhance the science and implementation of healthcare research focused on older adults from populations facing health disparities, specifically targeting improvements in screening, diagnostic, and clinical care guidelines, as well as fostering shared decision-making between clinicians and patients. The research is particularly significant for addressing the unique health challenges encountered by older adults from racial and ethnic minorities and underserved communities, emphasizing innovative care solutions that consider social determinants of health. Interested applicants can find more information and apply through the NIH Grants website, with the application opening on January 5, 2025, and a close date set for January 7, 2028. For inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov.
    NIA Program Project Applications (P01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NIA Program Project Grants (P01 Clinical Trial Optional), aimed at advancing research in aging-related scientific areas. Applicants must propose at least three interrelated research projects centered around a common theme, along with an administrative core to manage the initiative, addressing topics such as genetics, biology, and Alzheimer’s disease. This funding opportunity is crucial for fostering collaborative research efforts among established scientists and early-career researchers, ultimately contributing to the understanding and improvement of public health concerning aging. Interested organizations must submit their applications by September 7, 2025, and can find additional details and requirements at the provided NIH link or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for Complex Integrated Multi-Component Projects in Aging Research, designated as a U19 Clinical Trial Optional grant. This initiative aims to support large-scale, multidisciplinary research projects that address common questions related to aging, encouraging collaboration among investigators from various institutions. The program is particularly significant as it seeks to advance scientific knowledge in aging while addressing health disparities and promoting innovative research approaches. Interested applicants, including higher education institutions, nonprofits, and government agencies, can submit proposals until September 25, 2025, with a maximum project period of five years. For further inquiries, applicants may contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov, and additional details can be found at the provided link: http://grants.nih.gov/grants/guide/pa-files/PAR-22-213.html.
    Early- and Late-Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Early- and Late-Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline" grant, aimed at developing interventions to prevent or treat cognitive and behavioral changes associated with Alzheimer's disease (AD) and related dementias (ADRD). The funding opportunity seeks to support both pharmacological and non-pharmacological clinical trials, with a focus on enhancing trial design and methodologies to address the growing public health crisis posed by these conditions, which currently affect over 6 million Americans. The total funding allocation for fiscal year 2025 is approximately $20 million, with applications due by October 17, 2024. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for multidisciplinary research on HIV/AIDS and aging through the R21 Exploratory/Developmental Research Grant program. This initiative invites applications that aim to enhance the understanding of the biological, clinical, and socio-behavioral aspects of aging in the context of HIV infection, with specific objectives to improve prevention, testing, treatment strategies, and management of HIV-related health issues in diverse populations, particularly older adults aged 70 and above. The grant provides funding of up to $275,000 for a two-year period, with key submission dates starting April 4, 2024, and a closing date for applications set for January 7, 2027. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required), inviting applications for long-term clinical trials lasting 6 or 7 years. These trials must be hypothesis-driven, aligned with NIH's research mission, and include clearly defined objectives and milestone planning to monitor progress. This initiative emphasizes the importance of extended clinical trials in advancing critical biomedical research, with no specific budget limits but requiring justification based on project needs. Interested applicants must consult with NIH staff prior to submission, adhere to new application forms and data sharing policies, and submit their applications by January 13, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-084.html.
    Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)" aimed at advancing the science of aging through innovative research infrastructure. This initiative invites applications from a diverse range of eligible institutions to develop sustainable frameworks that address critical interdisciplinary questions in aging, with a focus on areas such as machine learning applications, health disparities, and behavioral aspects of aging. The funding mechanism provides up to five years of support, including two years for initial developmental activities and up to three years for expanded activities, with an award ceiling of $500,000. Interested applicants can find more information and application guidelines at the NIH website, and must submit their proposals by December 2, 2025, to be considered for this discretionary grant opportunity.
    NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Notice of Funding Opportunity (NOFO) for the NIAID Clinical Trial Implementation Cooperative Agreement (U01), aimed at supporting high-risk clinical trials that enhance the understanding of human diseases. This funding opportunity encourages applications for investigator-initiated, milestone-driven clinical trials, with each application permitted to propose only one clinical trial that must demonstrate a hypothesis-driven approach. The initiative emphasizes the importance of mechanistic studies within clinical trials and requires a robust plan for managing trial complexity and participant safety. Interested applicants can find additional details and guidelines at the provided NIH link, with the earliest submission date set for April 12, 2024, and the application deadline on January 13, 2027. For inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov.
    Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Heart, Lung, and Blood Institute (NHLBI), has announced a funding opportunity for Single-Site Investigator-Initiated Clinical Trials (R61/R33), aimed at supporting applications for clinical trials that test therapeutic, behavioral, or prevention strategies relevant to NHLBI's mission. This funding mechanism involves a bi-phasic award structure, with an initial R61 phase focused on protocol development followed by an R33 phase for trial execution, emphasizing comprehensive project management, subject recruitment, and community engagement. The initiative is particularly significant for advancing clinical research while promoting diversity among study participants and project teams. Interested applicants can find more details and submit proposals by September 12, 2025, and should direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.